Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome

Next Previous
Search
Trial Profile

Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Liraglutide (Primary) ; Metformin
  • Indications Obesity
  • Focus Therapeutic Use

Most Recent Events

  • 13 Jun 2017 Primary endpoint of change in body weight has not been met, according to results presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
  • 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association
  • 04 Apr 2017 Results of subset of patients proceeding to in vitro fertilisaztion presented at The 99th Annual Meeting of the Endocrine Society

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top